Steven Kregel

2.6k total citations · 1 hit paper
23 papers, 1.1k citations indexed

About

Steven Kregel is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Steven Kregel has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Steven Kregel's work include Prostate Cancer Treatment and Research (12 papers), Protein Degradation and Inhibitors (4 papers) and Cancer Cells and Metastasis (4 papers). Steven Kregel is often cited by papers focused on Prostate Cancer Treatment and Research (12 papers), Protein Degradation and Inhibitors (4 papers) and Cancer Cells and Metastasis (4 papers). Steven Kregel collaborates with scholars based in United States, Italy and Lebanon. Steven Kregel's co-authors include Donald J. Vander Griend, Russell Z. Szmulewitz, Yi Cai, Kristen Otto, Masis Isikbay, Jacob Kach, Suzanne D. Conzen, Nathan Sandbo, Sébastien Taurin and Gladell P. Paner and has published in prestigious journals such as Nature, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Steven Kregel

22 papers receiving 1.1k citations

Hit Papers

Biologically informed deep neural network for prostate ca... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Kregel United States 14 616 507 256 254 156 23 1.1k
Francesco Merolla Italy 25 845 1.4× 247 0.5× 209 0.8× 486 1.9× 59 0.4× 66 1.3k
Hayley C. Whitaker United Kingdom 22 699 1.1× 510 1.0× 184 0.7× 237 0.9× 118 0.8× 61 1.4k
Yi Zhu China 22 609 1.0× 343 0.7× 271 1.1× 125 0.5× 234 1.5× 75 1.2k
Shulin Wu United States 23 670 1.1× 691 1.4× 419 1.6× 342 1.3× 189 1.2× 63 1.6k
Kristian Ovaska Finland 13 753 1.2× 335 0.7× 202 0.8× 126 0.5× 206 1.3× 18 1.1k
Vladimir Valera United States 22 1.0k 1.7× 787 1.6× 681 2.7× 278 1.1× 170 1.1× 51 1.9k
Marko Laakso Finland 13 621 1.0× 318 0.6× 191 0.7× 115 0.5× 177 1.1× 20 924
Torvald Granfors Sweden 24 534 0.9× 1.0k 2.0× 335 1.3× 332 1.3× 75 0.5× 40 1.8k
Simon A. Williams United States 15 526 0.9× 185 0.4× 192 0.8× 344 1.4× 57 0.4× 26 995
Tatiana Vidaurre Peru 13 539 0.9× 184 0.4× 529 2.1× 583 2.3× 163 1.0× 56 1.2k

Countries citing papers authored by Steven Kregel

Since Specialization
Citations

This map shows the geographic impact of Steven Kregel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Kregel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Kregel more than expected).

Fields of papers citing papers by Steven Kregel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Kregel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Kregel. The network helps show where Steven Kregel may publish in the future.

Co-authorship network of co-authors of Steven Kregel

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Kregel. A scholar is included among the top collaborators of Steven Kregel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Kregel. Steven Kregel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fink, Emma C., David A. Cooper, Maarten C. Bosland, et al.. (2025). Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cells. Breast Cancer Research. 27(1). 10–10.
2.
Rullo, Anthony F., An Zhang, Samuel Yaw Aboagye, et al.. (2024). Pleiotropic anti-cancer activities of novel non-covalent thioredoxin reductase inhibitors against triple negative breast cancer. Free Radical Biology and Medicine. 227. 201–209. 5 indexed citations
3.
Williams, Anthony, Arunangsu Dey, Isha Kapoor, et al.. (2023). SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis. Cancer Letters. 565. 216209–216209. 11 indexed citations
4.
Williams, Anthony, Marc Gillard, Steven Kregel, et al.. (2022). SOX2 mediates metabolic reprogramming of prostate cancer cells. Oncogene. 41(8). 1190–1202. 48 indexed citations
5.
Darga, Elizabeth P., Fang Fang, Kelley M. Kidwell, et al.. (2021). PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer. PLoS ONE. 16(11). e0260124–e0260124. 38 indexed citations
6.
Elmarakeby, Haitham, Justin H. Hwang, Rand Arafeh, et al.. (2021). Biologically informed deep neural network for prostate cancer discovery. Nature. 598(7880). 348–352. 239 indexed citations breakdown →
7.
Kregel, Steven, Chao Wang, Xin Han, et al.. (2020). Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment. Neoplasia. 22(2). 111–119. 109 indexed citations
8.
Kregel, Steven, Rohit Malik, Irfan A. Asangani, et al.. (2019). Functional and Mechanistic Interrogation of BET Bromodomain Degraders for the Treatment of Metastatic Castration-resistant Prostate Cancer. Clinical Cancer Research. 25(13). 4038–4048. 26 indexed citations
9.
Kregel, Steven, Rohit Malik, Irfan A. Asangani, et al.. (2017). Abstract 2: Functional and mechanistic interrogation of BET bromodomain degraders for the treatment of metastatic castration resistant prostate cancer. Cancer Research. 77(13_Supplement). 2–2. 1 indexed citations
10.
Kregel, Steven, James L. Chen, Westin R. Tom, et al.. (2016). Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 7(18). 26259–26274. 78 indexed citations
11.
Reyes, Edwin E., Marc Gillard, Ryan Duggan, et al.. (2015). Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer.. Europe PMC (PubMed Central). 1(1). 17 indexed citations
12.
Isikbay, Masis, Kristen Otto, Steven Kregel, et al.. (2014). Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer. Hormones and Cancer. 5(2). 72–89. 212 indexed citations
13.
Kregel, Steven, Russell Z. Szmulewitz, & Donald J. Vander Griend. (2014). The pluripotency factor Nanog is directly upregulated by the Androgen Receptor in prostate cancer cells. The Prostate. 74(15). 1530–1543. 23 indexed citations
14.
Cai, Yi, Steven Kregel, & Donald J. Vander Griend. (2013). Formation of Human Prostate Epithelium Using Tissue Recombination of Rodent Urogenital Sinus Mesenchyme and Human Stem Cells. Journal of Visualized Experiments. 7 indexed citations
15.
Kregel, Steven, Kyle J. Kiriluk, Yi Cai, et al.. (2013). Sox2 Is an Androgen Receptor-Repressed Gene That Promotes Castration-Resistant Prostate Cancer. PLoS ONE. 8(1). e53701–e53701. 131 indexed citations
16.
Reyes, Edwin E., et al.. (2012). Growth kinetics of CD133‐positive prostate cancer cells. The Prostate. 73(7). 724–733. 12 indexed citations
17.
Zibara, Kazem, Fouad Boulos, Steven Kregel, et al.. (2011). Retinoic acid fails to induce cell cycle arrest with myogenic differentiation in rhabdomyosarcoma. Pediatric Blood & Cancer. 58(6). 877–884. 11 indexed citations
18.
Sandbo, Nathan, Steven Kregel, Sébastien Taurin, Sangeeta Bhorade, & Nickolai O. Dulin. (2009). Critical Role of Serum Response Factor in Pulmonary Myofibroblast Differentiation Induced by TGF-β. American Journal of Respiratory Cell and Molecular Biology. 41(3). 332–338. 94 indexed citations
19.
Yau, Douglas M., Nan Sethakorn, Sébastien Taurin, et al.. (2008). Regulation of Smad-Mediated Gene Transcription by RGS3. Molecular Pharmacology. 73(5). 1356–1361. 17 indexed citations
20.
Sandbo, Nathan, et al.. (2007). Downregulation of smooth muscle α-actin expression by bacterial lipopolysaccharide. Cardiovascular Research. 74(2). 262–269. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026